FDA inspection
Ningbo Renjian Pharmaceutical Group Co., Ltd: FDA inspection ending Aug 7, 2026
FDA inspection 1336222 · No Action Indicated (NAI) · Ningbo
Key facts
| Inspection ID | 1336222 |
|---|---|
| Firm | Ningbo Renjian Pharmaceutical Group Co., Ltd |
| FEI number | 3004160744 |
| City | Ningbo |
| Country | China |
| Fiscal year | 2026 |
| Inspection end date | Aug 7, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data